Barclays raised the firm’s price target on Molina Healthcare (MOH) to $164 from $144 and keeps an Underweight rating on the shares. The firm sees managed care stocks benefiting in 2026 from the prospects of margin expansion and rotation away from artificial intelligence-related stocks toward “de-rated underperformers.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Early notable gainers among liquid option names on December 31st
- Early notable gainers among liquid option names on December 30th
- Trump Trade: Trump strikes deals with nine drugmakers to cut prices
- President Trump says he’ll meet with insurance companies on price cuts
- Consumers left in limbo as ACA subsidies are not renewed, WSJ says